- Filed
- Apr 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Mar 31, 2026 | 1.37B sh |
| Shares Diluted | Q3 2026 · Feb 28, 2026 | 1.28B sh |
| Shares Diluted | Q3 2026 · Feb 28, 2026 | 1.26B sh |
| Shares Diluted | Q3 2026 · Feb 28, 2025 | 1.23B sh |
| Shares Diluted | Q3 2026 · Feb 28, 2025 | 1.23B sh |
| Operating Cash Flow | Q3 2026 · Feb 28, 2026 | −$12.32M |
| Operating Cash Flow | Q3 2026 · Feb 28, 2025 | −$3.1M |
| Cash And Equivalents | Q3 2026 · Feb 28, 2026 | $15.66M |
| Cash And Equivalents | Q3 2026 · May 31, 2025 | $11.9M |
| Stockholders Equity | Q3 2026 · Feb 28, 2026 | −$104.29M |
| Stockholders Equity | Q3 2026 · Nov 30, 2025 | −$119.75M |
| Stockholders Equity | Q3 2026 · Aug 31, 2025 | −$99.5M |
| Stockholders Equity | Q3 2026 · May 31, 2025 | −$96.04M |
| Stockholders Equity | Q3 2026 · Feb 28, 2025 | −$92.98M |
| Stockholders Equity | Q3 2026 · Nov 30, 2024 | −$89.39M |
| Stockholders Equity | Q3 2026 · Aug 31, 2024 | −$85.21M |
| Stockholders Equity | Q3 2026 · May 31, 2024 | −$116.76M |
| Current Liabilities | Q3 2026 · Feb 28, 2026 | $50.43M |
| Current Liabilities | Q3 2026 · May 31, 2025 | $70.52M |
| Total Liabilities | Q3 2026 · Feb 28, 2026 | $122.78M |
| Total Liabilities | Q3 2026 · May 31, 2025 | $114.09M |
| Current Assets | Q3 2026 · Feb 28, 2026 | $18.44M |
| Current Assets | Q3 2026 · May 31, 2025 | $17.88M |
| Total Assets | Q3 2026 · Feb 28, 2026 | $18.5M |
| Total Assets | Q3 2026 · May 31, 2025 | $18.05M |
| Eps Diluted | Q3 2026 · Feb 28, 2026 | $0.00 |
| Eps Diluted | Q3 2026 · Feb 28, 2026 | −$0.03 |
| Eps Diluted | Q3 2026 · Feb 28, 2025 | $0.00 |
| Eps Diluted | Q3 2026 · Feb 28, 2025 | $0.01 |
| Eps Basic | Q3 2026 · Feb 28, 2026 | $0.00 |
| Eps Basic | Q3 2026 · Feb 28, 2026 | −$0.03 |
| Eps Basic | Q3 2026 · Feb 28, 2025 | $0.00 |
| Eps Basic | Q3 2026 · Feb 28, 2025 | $0.01 |
| Sga Expense | Q3 2026 · Feb 28, 2026 | $1.65M |
| Sga Expense | Q3 2026 · Feb 28, 2026 | $5.17M |
| Sga Expense restated | Q3 2026 · Feb 28, 2025 | $1.52M |
| Sga Expense restated | Q3 2026 · Feb 28, 2025 | $5.42M |
| Net Income | Q3 2026 · Feb 28, 2026 | −$4.69M |
| Net Income | Q3 2026 · Feb 28, 2026 | −$32.84M |
| Net Income | Q3 2026 · Nov 30, 2025 | −$22.61M |
| Net Income | Q3 2026 · Aug 31, 2025 | −$5.54M |
| Net Income | Q3 2026 · Feb 28, 2025 | −$4.76M |
| Net Income | Q3 2026 · Feb 28, 2025 | $9.7M |
| Net Income | Q3 2026 · Nov 30, 2024 | −$4.77M |
| Net Income | Q3 2026 · Aug 31, 2024 | $19.23M |
| Operating Income | Q3 2026 · Feb 28, 2026 | −$6.3M |
| Operating Income | Q3 2026 · Feb 28, 2026 | −$32.94M |
| Operating Income | Q3 2026 · Feb 28, 2025 | −$4M |
| Operating Income | Q3 2026 · Feb 28, 2025 | $14.73M |